Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXETOR: Everolimus Effects on Metabolism and Exercise in Kidney Transplant
NCT01561404Phase 4Terminated
- Start
- Sep 2011
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of everolimus in kidney transplantation. Primary endpoints: Muscular strength and Oxygen consumption in the tissues. Started Sep 2011; status: terminated.
02
Drugs
everolimus
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT01561404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01561404.